Clinical Trial

Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 12, 2026 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a multicenter randomized controlled clinical trial designed to evaluate the clinical efficacy and cost-effectiveness of a digital health platform that integrates a symptom reporting and management software with a standardized telenursing program, allowing cancer patients to actively monitor, report, and self-manage chemotherapy-related adverse effects.
Trial Details
NCT Number NCT07405931
Lead Sponsor Ulsan University Hospital
Collaborators: National Cancer Center, Korea, Kosin University Gospel Hospital, Gyeongsang National University Hospital, Gachon University Gil Medical Center
Conditions Early Gastric Cancer, Advanced Gastric Cancer, Early Lung Cancer, Advanced Lung Cancer, Early Breast Cancer, Advanced Breast Cancer, Early Colon Cancer, Advanced Colon Cancer
Enrollment 414 participants
Start Date 2025-07-09
Primary Completion 2026-03 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-02-12